Quick Answer
SINOVAC BIOTECH LTD reported Gross Profit of $266.75 million for the year ending 2023.
- SINOVAC BIOTECH LTD showed a decrease of -67.0% in Gross Profit from 2022 to 2023.
- This data is from SINOVAC BIOTECH LTD's annual report (Form 10-K), filed with the SEC on April 29, 2024.
- XBRL data for this metric is available from 2009 to 2023 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 15 years of available data (2009 to 2023), SINOVAC BIOTECH LTD's Gross Profit has grown by 315.9%.
- Historical annual values: Fiscal year 2023: $266.75 million | Fiscal year 2022: $808.31 million | Fiscal year 2021: $18.30 billion | Fiscal year 2020: $443.44 million | Fiscal year 2019: $213.58 million | Fiscal year 2018: $204.93 million | Fiscal year 2017: $154.11 million | Fiscal year 2016: $50.04 million | Fiscal year 2015: $49.01 million | Fiscal year 2014: $47.46 million | Fiscal year 2013: $51.27 million | Fiscal year 2012: $30.12 million | Fiscal year 2011: $35.71 million | Fiscal year 2010: $16.68 million | Fiscal year 2009: $64.13 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: